5α-Reductase inhibitors increase acute coronary syndrome risk in patients with benign prostate hyperplasia

Journal of Endocrinological Investigation
C-H ChouC-H Kao

Abstract

This study explored the possible association between the use of two typical 5ARIs (finasteride and dutasteride) and the risk of acute coronary syndrome (ACS) in patients with benign prostate hyperplasia (BPH). From the claims data of the Taiwan National Health Insurance (NHI) Taiwan, we identified 1843 ACS cases among BPH patients and randomly selected 7330 controls without ACS, with a similar mean age of 73 years. Multivariate logistic regression analysis estimated the odds ratio (OR) and 95 % confidence interval (CI) for the relationship between the 5ARIs medications and ACS risk. We found that BPH patients who had received treatment with both finasteride and dutasteride were at a higher risk of ACS with an OR of 3.47 (95 % CI 1.05-11.5), compared to patients without 5ARIs treatment. Furthermore, the dosage analysis showed that there were no significant associations between ACS risk and uses of a single drug medication regardless the dosages. The ORs for those who took only dutasteride were 1.07 (95 % CI 0.39-2.99) with low dose and 0.73 (95 % CI 0.38-1.44) with high dose. The ORs for those who took only finasteride were 1.30 (95 % CI 0.89-1.92) with low dose and 0.98 (95 % CI 0.19-5.13) with high dose. This population-based ...Continue Reading

References

Jun 1, 1979·The Journal of Clinical Endocrinology and Metabolism·A W MeikleL I Dolman
Aug 1, 1992·The Journal of Clinical Endocrinology and Metabolism·R S RittmasterG J Gormley
Jul 1, 1992·The American Journal of the Medical Sciences·J A JacksonA M Spiekerman
Aug 1, 1971·The Journal of Clinical Investigation·T Ito, R Horton
Aug 1, 1993·The Journal of Clinical Investigation·A E ThigpenD W Russell
Jan 1, 1994·Annual Review of Biochemistry·D W Russell, J D Wilson
Jan 17, 2002·The New England Journal of Medicine·R S VasanD Levy
Dec 19, 2003·The New England Journal of Medicine·John D McConnellUNKNOWN Medical Therapy of Prostatic Symptoms (MTOPS) Research Group
May 6, 2004·The Journal of Clinical Endocrinology and Metabolism·Richard V ClarkStuart Hobbs
Sep 15, 2004·European Urology·Frans DebruyneUNKNOWN ARIA3001, ARIA3002 and ARIB3003 Study Investigators
Apr 6, 2005·Journal of the American College of Cardiology·John A SpertusUNKNOWN American College of Cardiology/American Heart Association Task Force on Performance Measures
Jun 20, 2006·Journal of the American Academy of Dermatology·Vera H PriceKeith D Kaufman
May 9, 2008·Differentiation; Research in Biological Diversity·Colin C Pritchard, Peter S Nelson
Jun 10, 2009·Circulation·Michael J PencinaRamachandran S Vasan
Feb 8, 2011·Journal of Endocrinological Investigation·G CoronaM Maggi
Aug 20, 2011·European Journal of Endocrinology·Giovanni CoronaMario Maggi
May 9, 2012·The Journal of Endocrinology·Linda VignozziMario Maggi
Jul 3, 2013·Journal of Clinical Pharmacy and Therapeutics·Y K LokeS Singh
Nov 7, 2013·JAMA : the Journal of the American Medical Association·Rebecca VigenP Michael Ho
Jan 25, 2014·Journal of Endocrinological Investigation·L VignozziM Maggi
Apr 2, 2014·International Journal of Endocrinology·Giovanni CoronaMario Maggi
Jul 2, 2014·Nature Reviews. Urology·Linda Vignozzi, Mario Maggi

❮ Previous
Next ❯

Citations

Mar 13, 2018·Current Opinion in Urology·Joo Yong Lee, Kang Su Cho

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.